Ferroptosis: A new strategy for targeting Alzheimer's disease

Neurochem Int. 2024 Sep:178:105773. doi: 10.1016/j.neuint.2024.105773. Epub 2024 May 23.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a complex pathogenesis, which involves the formation of amyloid plaques and neurofibrillary tangles. Many recent studies have revealed a close association between ferroptosis and the pathogenesis of AD. Factors such as ferroptosis-associated iron overload, lipid peroxidation, disturbances in redox homeostasis, and accumulation of reactive oxygen species have been found to contribute to the pathological progression of AD. In this review, we explore the mechanisms underlying ferroptosis, describe the link between ferroptosis and AD, and examine the reported efficacy of ferroptosis inhibitors in treating AD. Finally, we discuss the potential challenges to ferroptosis inhibitors use in the clinic, enabling their faster use in clinical treatment.

Keywords: Alzheimer's disease; Ferroptosis; Ferroptosis inhibitor; Lipid peroxidation.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Animals
  • Ferroptosis* / drug effects
  • Ferroptosis* / physiology
  • Humans
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / physiology
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species